Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites

Experimental Parasitology

Volumn 133, Issue 3, 2013, Pages 300-306

  Rico Mata, Rosa ^a   De Leon Rodriguez, Luis M ^a   Avila, Eva E ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

Author keywords

Antimicrobial peptides; Cathelicidin derived peptides; Entamoeba histolytica; Human cathelicidin; KR 20; LL 37

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYSTEINE PROTEINASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN KR 12; PROTEIN KR 20; PROTEIN KS 30; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENTAMOEBA HISTOLYTICA; ENZYME ACTIVITY; NONHUMAN; PARASITE INTEGRITY; PARASITE PHENOMENA AND FUNCTIONS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; TROPHOZOITE;

ANTIMICROBIAL CATIONIC PEPTIDES; ANTIPROTOZOAL AGENTS; CATHELICIDINS; CYSTEINE PROTEASES; ENTAMOEBA HISTOLYTICA; ERYTHROCYTES; HEMOLYSIS; HUMANS; PEPTIDE FRAGMENTS; TROPHOZOITES;

CANDIDA ALBICANS; ENTAMOEBA; ENTAMOEBA HISTOLYTICA; NEGIBACTERIA; POSIBACTERIA;

EID: 84872433200     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.12.009     Document Type: Article

References (38)

1. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000, 96:3086-3093.
2. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 1995, 92:195-199.
3. Anderson R.C., Yu P.L. Factors affecting the antimicrobial activity of ovine-derived cathelicidins against E. coli 0157:H7. Int. J. Antimicrob. Agents 2005, 25:205-210.
4. Braff M.H., Hawkins M.A., Di Nardo A., Lopez-Garcia B., Howell M.D., Wong C., Lin K., Streib J.E., Dorschner R., Leung D.Y., Gallo R.L. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 2005, 174:4271-4278.
5. Chan W., White P. FMOC Solid Phase Peptide Synthesis: A Practical Approach. Practical Approach Series 2000, Oxford University Press, USA.
6. Ciornei C.D., Sigurdardottir T., Schmidtchen A., Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob. Agents Chemother. 2005, 49:2845-2850.
7. Cobo E.R., He C., Hirata K., Hwang G., Tran U., Eckmann L., Gallo R.L., Reed S.L. Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing. Infect. Immun. 2012, 80:143-149.
8. Cowland J.B., Johnsen A.H., Borregaard N. HCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 1995, 368:173-176.
9. Den Hertog A.L., van Marle J., Veerman E.C., Valentijn-Benz M., Nazmi K., Kalay H., Grun C.H., Van't Hof W., Bolscher J.G., Nieuw Amerongen A.V. The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol. Chem. 2006, 387:1495-1502.
10. Di Nardo A., Vitiello A., Gallo R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 2003, 170:2274-2278.
11. Diamond L.S., Harlow D.R., Cunnick C.C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 1978, 72:431-432.
12. Dorschner R.A., Lopez-Garcia B., Peschel A., Kraus D., Morikawa K., Nizet V., Gallo R.L. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 2006, 20:35-42.
13. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., Agerberth B., Gudmundsson G.H., Gallo R.L. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 2001, 117:91-97.
14. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., Gudmundsson G.H. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 1997, 272:15258-15263.
15. Frohm N., Sandstedt B., Sorensen O., Weber G., Borregaard N., Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 1999, 67:2561-2566.
16. Goldman M.J., Anderson G.M., Stolzenberg E.D., Kari U.P., Zasloff M., Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997, 88:553-560.
17. Hase K., Eckmann L., Leopard J.D., Varki N., Kagnoff M.F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 2002, 70:953-963.
18. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 1998, 273:3718-3724.
19. Keene W.E., Petitt M.G., Allen S., McKerrow J.H. The major neutral proteinase of Entamoeba histolytica. J. Exp. Med. 1986, 163:536-549.
20. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 1995, 63:1291-1297.
21. Li E., Yang W.G., Zhang T., Stanley S.L. Interaction of laminin with Entamoeba histolytica cysteine proteinases and its effect on amebic pathogenesis. Infect. Immun. 1995, 63:4150-4153.
22. Li X., Li Y., Han H., Miller D.W., Wang G. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region. J. Am. Chem. Soc. 2006, 128:5776-5785.
23. Lopez-Soto F., Leon-Sicairos N., Nazmi K., Bolscher J.G., de la Garza M. Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica. Biometals 2010, 23:563-568.
24. Murakami M., Lopez-Garcia B., Braff M., Dorschner R.A., Gallo R.L. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 2004, 172:3070-3077.
25. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414:454-457.
26. Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 1999, 341:501-513.
27. Pestonjamasp V.K., Huttner K.H., Gallo R.L. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 2001, 22:1643-1650.
28. Preet S., Bharati S., Shukla G., Koul A., Rishi P. Evaluation of amoebicidal potential of Paneth cell cryptdin-2 against Entamoeba histolytica. PLoS Negl. Trop. Dis. 2011, 5:e1386.
29. Radzishevsky I.S., Rotem S., Zaknoon F., Gaidukov L., Dagan A., Mor A. Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob. Agents Chemother. 2005, 49:2412-2420.
30. Ramos R., Silva J.P., Rodrigues A.C., Costa R., Guardao L., Schmitt F., Soares R., Vilanova M., Domingues L., Gama M. Wound healing activity of the human antimicrobial peptide LL37. Peptides 2011, 32:1469-1476.
31. Schägger H. Tricine-SDS-PAGE. Nat. Protoc. 2006, 1:16-22.
32. Sigurdardottir T., Andersson P., Davoudi M., Malmsten M., Schmidtchen A., Bodelsson M. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob. Agents Chemother. 2006, 50:2983-2989.
33. Stanley S.L., Zhang T., Rubin D., Li E. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect. Immun. 1995, 63:1587-1590.
34. Tollin M., Bergman P., Svenberg T., Jornvall H., Gudmundsson G.H., Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 2003, 24:523-530.
35. Walsh J.A. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev. Infect. Dis. 1986, 8:228-238.
36. Wang G. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 2008, 283:32637-32643.
37. Ximenez C., Moran P., Rojas L., Valadez A., Gomez A. Reassessment of the epidemiology of amebiasis: state of the art. Infect. Genet. Evol. 2009, 9:1023-1032.
38. Zaiou M., Gallo R.L. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. (Berl) 2002, 80:549-561.